Pulmonary Aspergillosis
📧 Sign up to get email alerts when something new happens for Pulmonary Aspergillosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI)
Clinical trial update noting that the study on COVID-19 associated pulmonary aspergillosis and other invasive fungal infections has complete…
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Voriconazole Inhalation Powder for the Treatment of Pulmonary Aspergillosis
ClinicalTrials.gov update on a voriconazole inhalation powder trial for pulmonary aspergillosis; the study is no longer available.
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment [Phase 3]
Phase 3 study assessing ibrexafungerp in patients with invasive and mucocutaneous fungal diseases refractory to or intolerant of standard tr…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: A Safety Study of PC945 (Opelconazole) Prophylaxis or Pre-emptive Therapy Against Pulmonary Aspergillosis in Lung Transplant Recipients (OPERA-S Study) [Phase 2]
Phase 2 safety trial evaluating Opelconazole (PC945) for prophylaxis or pre-emptive therapy against pulmonary aspergillosis in lung transpla…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Uniportal VATS Resection for Pulmonary Aspergilloma : Evaluation of Prognostic Factors in a Single Center Experience [NA]
A completed single-center study evaluates uniportal video-assisted thoracoscopic resection for pulmonary aspergilloma and analyzes prognosti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: A Randomized Controlled Trial to Compare the Clinical Outcomes With Six Months of Therapy With Oral Itraconazole Versus Oral Voriconazole for Management of Treatment naïve Subjects With Chronic Pulmonary Aspergillosis [Phase 3]
Phase 3 randomized trial comparing six months of oral itraconazole versus oral voriconazole for treatment-naïve chronic pulmonary aspergillo…
-
CLINICAL_TRIALS trial_result · 2021-10-12Clinical Trial Update: Six Months Versus 12 Months of Oral Itraconazole Therapy for Management of Treatment naïve Subjects With CPA [Phase 3]
Phase 3 trial comparing six months versus twelve months of oral itraconazole for treatment-naïve chronic pulmonary aspergillosis.
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Treatment of Aspergillus Fumigatus (a Fungal Infection) in Patients With Cystic Fibrosis [Phase 4]
A Phase 4 clinical trial evaluating treatment for Aspergillus fumigatus infection in cystic fibrosis patients has completed, with results po…
-
CLINICAL_TRIALS trial_result · 2016-06-28Clinical Trial Update: Duplication in CHIT1 Gene and the Risk for Aspergillus Lung Disease in CF Patients
A completed clinical trial investigates whether duplication in the CHIT1 gene alters the risk of pulmonary aspergillosis in cystic fibrosis …